A mechanism similar to this one has already been alluded to in the Irf5−/− pristane-induced model of lupus, where loss of Irf5 results in an increase in the production of the Th2-specific cytokines IL-4 and IL-5 (41, 42, 56). The gene discussed is IL4; the disease is systemic lupus erythematosus.